Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Ideas
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Tools
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
News
Enterprise Solutions
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
More
Plans
News
Trending
Portfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Ideas
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Tools
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
Log Out
CTMX
Stock Latest News
The Fly
CytomX Therapeutics announces first patient dosed with CX-801
11d ago
CTMX
Premium
Press Releases
CytomX Therapeutics Announces First Patient Dosed with CX-801, a Dually-Masked Interferon-Alpha 2b PROBODY®, in a Phase 1 Study in Patients with Solid Tumors
11d ago
CTMX
Premium
The Fly
CytomX Therapeutics files $250M mixed securities shelf
1M ago
CTMX
Premium
The Fly
CytomX Therapeutics reports Q2 EPS (8c), consensus (14c)
1M ago
CTMX
Premium
Press Releases
CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
1M ago
CTMX
Premium
Pre-Earnings
CTMX Earnings this Week: How Will it Perform?
1M ago
CTMX
Premium
Press Releases
CytomX Therapeutics to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference
3M ago
CTMX
Premium
Company Announcements
CytomX Therapeutics Appoints Chris Ogden as New CFO
3M ago
8K
CTMX
Premium
Press Releases
CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer
3M ago
CTMX
Premium
The Fly
CytomX Therapeutics promotes Chris Ogden to CFO
3M ago
CTMX
Premium
The Fly
Largest borrow rate increases among liquid names
4M ago
EA
SU
Premium
The Fly
CytomX upgraded on pancreatic cancer data at Piper Sandler
4M ago
CTMX
Premium
The Fly
CytomX Therapeutics upgraded to Overweight from Neutral at Piper Sandler
4M ago
CTMX
Premium
Press Releases
CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference
4M ago
CTMX
Premium
The Fly
Largest borrow rate increases among liquid names
4M ago
ENB
LAC
Premium
Press Releases
CytomX Therapeutics Announces New Employment Inducement Grants
4M ago
CTMX
Premium
The Fly
Largest borrow rate increases among liquid names
4M ago
ADP
UCO
Premium
The Fly
Wedbush upgrades CytomX to Outperform on ‘encouraging’ CX-904 Phase 1a data
4M ago
AMGN
CTMX
Premium
The Fly
CytomX Therapeutics upgraded to Outperform from Neutral at Wedbush
4M ago
CTMX
Premium
The Fly
CytomX Therapeutics announces initial data from CX-904 trial
4M ago
CTMX
Premium
The Fly
CytomX Therapeutics reports Q1 EPS 17c, consensus (8c)
4M ago
CTMX
Premium
Press Releases
CytomX Therapeutics Announces Positive Initial Phase 1a Dose Escalation Data for Monotherapy CX-904 (EGFRxCD3 PROBODY® T-Cell Engager)
4M ago
CTMX
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
